Hua Cai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hua Cai has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
Ji Youn Youn
Division of Molecular Medicine, Department of Anesthesiology, Division of Cardiology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, USA
20 shared publicationsKin Lung Siu
Division of Molecular Medicine, Department of Anesthesiology and Perioperative Medicine, Division of Cardiology, Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA, 90095, USA
15 shared publicationsYixuan Zhang
Division of Molecular Medicine, Department of Anesthesiology and Perioperative Medicine, Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (K.H., Y.H., Yuhan Zhang, Yixuan Zhang, N.W.H., H.C.).
13 shared publicationsQiang Li
Division of Molecular Medicine, Department of Anesthesiology and Perioperative Medicine, Division of Cardiology, Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA, 90095, USA
12 shared publicationsKai Huang
Division of Molecular Medicine, Department of Anesthesiology, Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, California, 90095, USA
11 shared publications- Yixuan Zhang
Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Graduate School of the Chinese Academy of Sciences, Shanghai, China
10 shared publications
Latest Publications
- Open Access
- 22 May 2026
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 138 (11) , e326768
Endothelial NOX1 Drives Obesity via Skeletal Muscle Mitochondrial Dysfunction
BACKGROUND: Presently, we investigated hypothesized roles and mechanisms of cell type–specific, selective activation of different vascular NOX (NADPH oxidase) isoforms in obesity and metabolic syndrome. Methods: Wild-type, NOX1/2/4 global knockout mice, endothelial/VSMC-specific NOX1 knockout mice, or vascular endothelial-speicifc NOX1 knockin mice were exposed to high-fat diet feeding prior to phenotypical analyses of obesity and metabolic syndrome, as well as of exercise capacity, skeletal muscle mitochondrial function, and novel genetic signatures. Results: Expression of NOX1 was significantly upregulated in wild-type mice fed a high-fat diet. Global knockout of NOX1 (NOX1 −/y ), rather than of NOX2/NOX4, markedly abrogated high-fat feeding–induced body weight/fat mass gain, preadipocyte differentiation, fatty liver, glucose intolerance, and insulin/leptin resistance. Intriguingly, endothelial-specific NOX1 knockout (Cdh5cre [cadherin 5 (vascular endothelial cadherin) promoter–driven Cre recombinase (endothelial-specific Cre expression)]-NOX1CKO), rather than vascular smooth muscle-specific NOX1 knockout (Myh11cre [myosin heavy chain 11 promoter–driven Cre recombinase (smooth muscle–specific Cre expression)]-NOX1CKO), substantially alleviated obesity and metabolic syndrome. Consistently, endothelial-specific NOX1 knockin mice (Cdh5cre-NOX1CKI) fed a high-fat diet displayed exaggerated metabolic disorders. Endothelial cell–specific knockout/knockin of NOX1 was confirmed using endothelial cell washout experiments. Food/water intakes were not different from corresponding controls in high-fat fed NOX1 −/y , Cdh5cre-NOX1CKO, or Cdh5cre-NOX1CKI mice, indicating no difference in energy intake. Instead, spontaneous activity, exercise capacity, mitochondrial oxygen consumption/ATP production, skeletal muscle mitochondrial function (ROS production and swelling activity), and mitochondrial cristae structure were all substantially improved in NOX1 −/y or Cdh5cre-NOX1CKO mice, indicating augmented energy expenditure attributed to preserved skeletal muscle mitochondrial function. Supportively, Cdh5cre-NOX1CKI mice displayed deteriorated exercise capacity and skeletal muscle mitochondrial dysfunction. Endothelium-dependent vasorelaxation was restored in high-fat fed NOX1 −/y or Cdh5cre-NOX1CKO mice, confirming improved endothelial function. RNA-sequencing identified 4 genes ( Cntnap4 [contactin-associated protein-like 4], Sgsm1 , Tll2 , and Syt9 ) and 7 genes ( Odf3l2 , Col9a1 [collagen type IX alpha 1 chain], Cldn23 , Atp5g2 , Nkx6-3 , Ntsr2 , and Zfp69 ) significantly downregulated/upregulated in high-fat fed Cdh5cre-NOX1CKO mice, among which Cntnap4 and Col9a1 linked to muscular disorders. Importantly, we observed marked upregulation of NOX1 in isolated coronary arteries from human patients with obesity. CONCLUSIONS: Taken together, our data for the first time establish a novel and paradigm-shifting concept that endothelial NOX1 drives systematic metabolic phenotypes, via impairment in skeletal muscle mitochondrial dysfunction with novel genetic signatures. Tissue-specific targeting of endothelial NOX1 and novel candidate genes may prove to be robustly effective in treating obesity and metabolic syndrome.
- 22 May 2026
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 138 (11) , e326768
Open AccessEndothelial NOX1 Drives Obesity via Skeletal Muscle Mitochondrial Dysfunction
BACKGROUND: Presently, we investigated hypothesized roles and mechanisms of cell type–specific, selective activation of different vascular NOX (NADPH oxidase) isoforms in obesity and metabolic syndrome. Methods: Wild-type, NOX1/2/4 global knockout mice, endothelial/VSMC-specific NOX1 knockout mice, or vascular endothelial-speicifc NOX1 knockin mice were exposed to high-fat diet feeding prior to phenotypical analyses of obesity and metabolic syndrome, as well as of exercise capacity, skeletal muscle mitochondrial function, and novel genetic signatures. Results: Expression of NOX1 was significantly upregulated in wild-type mice fed a high-fat diet. Global knockout of NOX1 (NOX1 −/y ), rather than of NOX2/NOX4, markedly abrogated high-fat feeding–induced body weight/fat mass gain, preadipocyte differentiation, fatty liver, glucose intolerance, and insulin/leptin resistance. Intriguingly, endothelial-specific NOX1 knockout (Cdh5cre [cadherin 5 (vascular endothelial cadherin) promoter–driven Cre recombinase (endothelial-specific Cre expression)]-NOX1CKO), rather than vascular smooth muscle-specific NOX1 knockout (Myh11cre [myosin heavy chain 11 promoter–driven Cre recombinase (smooth muscle–specific Cre expression)]-NOX1CKO), substantially alleviated obesity and metabolic syndrome. Consistently, endothelial-specific NOX1 knockin mice (Cdh5cre-NOX1CKI) fed a high-fat diet displayed exaggerated metabolic disorders. Endothelial cell–specific knockout/knockin of NOX1 was confirmed using endothelial cell washout experiments. Food/water intakes were not different from corresponding controls in high-fat fed NOX1 −/y , Cdh5cre-NOX1CKO, or Cdh5cre-NOX1CKI mice, indicating no difference in energy intake. Instead, spontaneous activity, exercise capacity, mitochondrial oxygen consumption/ATP production, skeletal muscle mitochondrial function (ROS production and swelling activity), and mitochondrial cristae structure were all substantially improved in NOX1 −/y or Cdh5cre-NOX1CKO mice, indicating augmented energy expenditure attributed to preserved skeletal muscle mitochondrial function. Supportively, Cdh5cre-NOX1CKI mice displayed deteriorated exercise capacity and skeletal muscle mitochondrial dysfunction. Endothelium-dependent vasorelaxation was restored in high-fat fed NOX1 −/y or Cdh5cre-NOX1CKO mice, confirming improved endothelial function. RNA-sequencing identified 4 genes ( Cntnap4 [contactin-associated protein-like 4], Sgsm1 , Tll2 , and Syt9 ) and 7 genes ( Odf3l2 , Col9a1 [collagen type IX alpha 1 chain], Cldn23 , Atp5g2 , Nkx6-3 , Ntsr2 , and Zfp69 ) significantly downregulated/upregulated in high-fat fed Cdh5cre-NOX1CKO mice, among which Cntnap4 and Col9a1 linked to muscular disorders. Importantly, we observed marked upregulation of NOX1 in isolated coronary arteries from human patients with obesity. CONCLUSIONS: Taken together, our data for the first time establish a novel and paradigm-shifting concept that endothelial NOX1 drives systematic metabolic phenotypes, via impairment in skeletal muscle mitochondrial dysfunction with novel genetic signatures. Tissue-specific targeting of endothelial NOX1 and novel candidate genes may prove to be robustly effective in treating obesity and metabolic syndrome.
- Open Access
- 24 March 2026
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 11 (4) , 101512
eNOS Uncoupling-ER Stress-Mitochondrial Dysfunction Axis in the Development of Pulmonary Hypertension
- 24 March 2026
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 11 (4) , 101512
Open AccesseNOS Uncoupling-ER Stress-Mitochondrial Dysfunction Axis in the Development of Pulmonary Hypertension
- Open Access
- 1 January 2026
- Published by SCIE Publishing Limited in Journal of Respiratory Biology and Translational Medicine
- Vol. 3 (2) , 10004
Striking Surge in Lung Cancer Incidence in Children of Early Life
SCIEPublish is an international open-access journal publishing service provider run by SCIE Publishing Limited, dedicated to supporting and inspiring scientists or institutions/societies who aspire to publish high-quality journals.
- 1 January 2026
- Published by SCIE Publishing Limited in Journal of Respiratory Biology and Translational Medicine
- Vol. 3 (2) , 10004
Open AccessStriking Surge in Lung Cancer Incidence in Children of Early Life
SCIEPublish is an international open-access journal publishing service provider run by SCIE Publishing Limited, dedicated to supporting and inspiring scientists or institutions/societies who aspire to publish high-quality journals.
- Open Access
- 1 October 2025
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 34 (178) , 250170
Keep e-cigarette vaping away from juveniles: immediate interventions
Tobacco use has been falling for decades in developed countries, yet smoking remains one of the leading causes of preventable death globally [1]. Importantly, electronic nicotine delivery systems (ENDS; also known as e-cigarettes) are gaining in prevalence (4.5% increase between 2018 and 2022 in the USA) [2], with contributions from vaping gadgets appealing to teenagers [3]. This is a massive problem at the global scale, and is echoed by similar trends revealed in Europe [4] and Asia [5].
- 1 October 2025
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 34 (178) , 250170
Open AccessKeep e-cigarette vaping away from juveniles: immediate interventions
Tobacco use has been falling for decades in developed countries, yet smoking remains one of the leading causes of preventable death globally [1]. Importantly, electronic nicotine delivery systems (ENDS; also known as e-cigarettes) are gaining in prevalence (4.5% increase between 2018 and 2022 in the USA) [2], with contributions from vaping gadgets appealing to teenagers [3]. This is a massive problem at the global scale, and is echoed by similar trends revealed in Europe [4] and Asia [5].
- Open Access
- 1 October 2025
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 45 (10) , 1784-1798
Trimethylamine- N -Oxide Affects Cell Type–Specific Pathways and Networks in Mouse Aorta to Promote Atherosclerotic Plaque Vulnerability
BACKGROUND: Trimethylamine- N -oxide (TMAO) has been significantly linked to atherosclerosis via several mechanisms, but its direct effect on the atherosclerosis-prone vasculature remains unclear. The objective of this study was to characterize the cell type–dependent and independent effects of TMAO on key vascular cell types involved in atherosclerosis progression in vivo. METHODS: We performed single-cell RNA-sequencing on aortic athero-prone regions of female Ldlr −/− mice fed normal laboratory, high-cholesterol, or high-cholesterol+TMAO diets for 3 months to identify which aortic cell types, differentially expressed genes, and biological pathways are affected by TMAO. We also modeled cell-cell communications and intracellular gene regulatory networks to identify gene networks perturbed by TMAO feeding. Key genes and pathways were validated using human vascular smooth muscle cells (vSMCs) exposed to TMAO. Changes in fibrous cap thickness, macrophage content, and collagen deposition in response to TMAO were measured with immunostaining and histology and quantified. RESULTS: Our single-cell RNA-sequencing analysis revealed that TMAO supplementation upregulated apoptotic gene signatures and downregulated extracellular matrix (ECM) organization and collagen formation genes in a subset of atherosclerosis-specific modulated vSMCs. We also identified degradation of the ECM as a top pathway for vSMC-derived macrophage differentially expressed genes in response to TMAO. Network analyses supported that macrophage-vSMC communication mediates ECM remodeling. Using human smooth muscle cells exposed to TMAO in vitro, we confirmed the direct effect of TMAO on regulating collagen and apoptotic genes. In agreement with the changes in these pathways that affect plaque stability, we observed a significant decrease in fibrous cap thickness and collagen deposition in mice supplemented with TMAO. CONCLUSIONS: Our results reveal the effects of TMAO on vSMCs to promote apoptosis and decrease ECM formation and on macrophage-mediated ECM degradation to, in concert enhance atherosclerotic plaque instability.
- 1 October 2025
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 45 (10) , 1784-1798
Open AccessTrimethylamine- N -Oxide Affects Cell Type–Specific Pathways and Networks in Mouse Aorta to Promote Atherosclerotic Plaque Vulnerability
BACKGROUND: Trimethylamine- N -oxide (TMAO) has been significantly linked to atherosclerosis via several mechanisms, but its direct effect on the atherosclerosis-prone vasculature remains unclear. The objective of this study was to characterize the cell type–dependent and independent effects of TMAO on key vascular cell types involved in atherosclerosis progression in vivo. METHODS: We performed single-cell RNA-sequencing on aortic athero-prone regions of female Ldlr −/− mice fed normal laboratory, high-cholesterol, or high-cholesterol+TMAO diets for 3 months to identify which aortic cell types, differentially expressed genes, and biological pathways are affected by TMAO. We also modeled cell-cell communications and intracellular gene regulatory networks to identify gene networks perturbed by TMAO feeding. Key genes and pathways were validated using human vascular smooth muscle cells (vSMCs) exposed to TMAO. Changes in fibrous cap thickness, macrophage content, and collagen deposition in response to TMAO were measured with immunostaining and histology and quantified. RESULTS: Our single-cell RNA-sequencing analysis revealed that TMAO supplementation upregulated apoptotic gene signatures and downregulated extracellular matrix (ECM) organization and collagen formation genes in a subset of atherosclerosis-specific modulated vSMCs. We also identified degradation of the ECM as a top pathway for vSMC-derived macrophage differentially expressed genes in response to TMAO. Network analyses supported that macrophage-vSMC communication mediates ECM remodeling. Using human smooth muscle cells exposed to TMAO in vitro, we confirmed the direct effect of TMAO on regulating collagen and apoptotic genes. In agreement with the changes in these pathways that affect plaque stability, we observed a significant decrease in fibrous cap thickness and collagen deposition in mice supplemented with TMAO. CONCLUSIONS: Our results reveal the effects of TMAO on vSMCs to promote apoptosis and decrease ECM formation and on macrophage-mediated ECM degradation to, in concert enhance atherosclerotic plaque instability.
- Open Access
- 13 June 2025
- Published by Elsevier in Redox Biology
- Vol. 85, 103710
Novel and superior treatment of pulmonary hypertension with netrin-1 derived, modified and improved small peptides
- 13 June 2025
- Published by Elsevier in Redox Biology
- Vol. 85, 103710
Open AccessNovel and superior treatment of pulmonary hypertension with netrin-1 derived, modified and improved small peptides
- 1 March 2025
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 328 (3) , L430-L442
Enhanced lung endothelial glycolysis is implicated in the development of severe pulmonary hypertension in type 2 diabetes
Increasing evidence shows that diabetes exacerbates the progression of pulmonary hypertension; however, its molecular mechanisms are understudied. In this study, we revealed that augmented glycolysis in diabetic pulmonary endothelial cells is involved in the development of severe PH in diabetes. Inhibition of glycolysis could be a therapeutic strategy for treating pulmonary hypertension in patients with diabetes.
- 1 March 2025
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 328 (3) , L430-L442
Enhanced lung endothelial glycolysis is implicated in the development of severe pulmonary hypertension in type 2 diabetes
Increasing evidence shows that diabetes exacerbates the progression of pulmonary hypertension; however, its molecular mechanisms are understudied. In this study, we revealed that augmented glycolysis in diabetic pulmonary endothelial cells is involved in the development of severe PH in diabetes. Inhibition of glycolysis could be a therapeutic strategy for treating pulmonary hypertension in patients with diabetes.
- Open Access
- 27 February 2025
- Published by Elsevier in Redox Biology
- Vol. 82, 103570
Alleviation of accelerated diabetic atherogenesis in STZ-treated apoE/NOX1 DKO mice, apoE−/−/tg-EC-DHFR mice, and by folic acid
- 27 February 2025
- Published by Elsevier in Redox Biology
- Vol. 82, 103570
Open AccessAlleviation of accelerated diabetic atherogenesis in STZ-treated apoE/NOX1 DKO mice, apoE−/−/tg-EC-DHFR mice, and by folic acid
- Open Access
- 13 December 2024
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 35 (4) , 221-229
Expand the success of screening to reduce aortic aneurysm mortality: progress interpretation and new fronts
- 13 December 2024
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 35 (4) , 221-229
Open AccessExpand the success of screening to reduce aortic aneurysm mortality: progress interpretation and new fronts